🇺🇸 FDA

Drug profile · INN

olanzapine

OLANZAPINE GLENMARK

approved N05AH03
US status
approved
Patents linked
3
News articles
0

Quick answer

olanzapine (OLANZAPINE GLENMARK) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: intramuscular. Current US regulatory status: approved.

Key facts

INN olanzapine
Brand OLANZAPINE GLENMARK
Route INTRAMUSCULAR
Formulation TABLET, ORALLY DISINTEGRATING
ATC code N05AH03
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 11813359

    Sustained release olanzapine formulations

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10646443

    Sustained release olanzapine formulations

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7323459

    Crystal forms, methods for their preparation and method for preparation of olanzapine

    Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is olanzapine?

olanzapine (OLANZAPINE GLENMARK) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: intramuscular. Current US regulatory status: approved.

What is the brand name for olanzapine?

OLANZAPINE GLENMARK is a marketed brand name for olanzapine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of olanzapine?

olanzapine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.